Inflammatory bowel disease in Scottish children

Area of Science:

• Pediatric Gastroenterology
• Inflammatory Bowel Disease (IBD) Research
• Clinical Pediatrics

Background:

• Inflammatory bowel disease (IBD) in children often necessitates specialized care at tertiary centers.
• A retrospective analysis was conducted on pediatric IBD cases managed at a specific hospital over two decades.

Purpose of the Study:

• To analyze the clinical characteristics, diagnosis, treatment, and outcomes of pediatric inflammatory bowel disease (IBD) cases.
• To identify trends in the incidence of Crohn's disease (CD) and ulcerative colitis (UC) in children.
• To evaluate diagnostic delays and treatment modalities in pediatric IBD.

Main Methods:

• Retrospective review of medical records for 105 children diagnosed with IBD between 1976 and 1995.
• Data collection included age at presentation, diagnosis (Crohn's disease (CD) or ulcerative colitis (UC)), time to diagnosis, treatment, relapse rates, and growth parameters.
• Statistical analysis to compare CD and UC patient groups and identify trends over time.

Main Results:

• Crohn's disease (CD) incidence doubled between 1986-1995 compared to 1975-1985; median ages of presentation were 7.9 years for CD and 8.7 years for UC.
• Median time to diagnosis was significantly longer for CD (45.8 weeks) than for UC (12.7 weeks).
• Aminosalicylates were the primary treatment; surgery was infrequent. Many patients experienced growth impairment, with low height-for-age Z scores.

Conclusions:

• Pediatric inflammatory bowel disease (IBD), particularly Crohn's disease (CD), shows increasing incidence and significant diagnostic delays.
• Growth impairment is a common issue in pediatric IBD patients, highlighting the need for monitoring and intervention.
• While aminosalicylates are a common treatment, outcomes regarding relapse and growth require further investigation.